These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3226595)

  • 21. Distinctive biology of pleomorphic lobular carcinoma of the breast.
    Moe RE; Anderson BO
    J Surg Oncol; 2005 May; 90(2):47-50. PubMed ID: 15844193
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Standardization of receptor diagnosis in breast cancer].
    Hickler W; Scheiermann N; Riffelmann HD; Kreuzfelder E
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1931-3. PubMed ID: 3780470
    [No Abstract]   [Full Text] [Related]  

  • 24. Value of B72.3 staining in "suspicious" fine needle aspiration biopsies of the breast.
    Pohoresky J; Yazdi HM
    Acta Cytol; 1991; 35(2):254-5. PubMed ID: 2028702
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of normal and tumor-associated antigens in human breast carcinoma.
    Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
    Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic factors in breast cancer].
    Jonat W; Eidtmann H; Friedrichs K
    Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
    [No Abstract]   [Full Text] [Related]  

  • 28. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 30. Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
    Badve S
    Breast Cancer Res Treat; 2009 Jul; 116(1):145-7. PubMed ID: 18787946
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monoclonal antibodies in diagnosis of breast cancer].
    Karsten U
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):987-92. PubMed ID: 1776290
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of steroid hormone receptors with respect to tumor cellularity.
    Geppert M; Smyczek-Gargya B; Dietl J; Schneider H
    Zentralbl Pathol; 1993 Aug; 139(3):217-9. PubMed ID: 8218122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of immunohistochemistry in diagnosis of breast epithelial lesions.
    Bhargava R; Dabbs DJ
    Adv Anat Pathol; 2007 Mar; 14(2):93-107. PubMed ID: 17471116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prognostic and predictive factors in breast cancer].
    Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE
    Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of estrogen receptors of breast carcinoma with the PAP method. Retrospective study from 1979 to 1985].
    Giudici M; Cartia GL; Ciambellotti E; Langè A
    Pathologica; 1987; 79(1059-1060):61-3. PubMed ID: 3327047
    [No Abstract]   [Full Text] [Related]  

  • 40. [Monoclonal antibodies in the diagnosis of breast carcinoma].
    Beketić-Oresković L; Novak D
    Lijec Vjesn; 1992; 114(5-8):157-60. PubMed ID: 1343051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.